EUVIMEDEUVIMED entdecken
Crossref

[12]aneN 3 -modified camptothecin and PEGylated AIEgens co-assembly into core–shell nanoparticles with ROS/NTR dual-response for enhanced cancer therapy

Xue-Yi Sun, Ya-Xuan Liang, Yi-Nan Gao, Xi Zhang, Rui Liu, Quan Tang, Zhong-Lin Lu iD, Yang Liu iD

Journal of Materials Chemistry B · 2023

DOI: 10.1039/d3tb01282d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2023. Verfasst von Xue-Yi Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Radiopharmaceutics, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China. quantang@bnu.e…. Hauptthemen laut MEDLINE: Prodrugs, Nanoparticles, Nucleic Acids, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel dual-responsive core–shell nanoparticle (NP) system was successfully constructed for cancer treatment with synergistic drug/gene therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNanoparticlesNucleic AcidsNeoplasmsHumansHeLa CellsReactive Oxygen SpeciesNitroreductasesCamptothecinPolyethylene Glycols

Substanzen

ProdrugsReactive Oxygen SpeciesNitroreductasesNucleic AcidsCamptothecinPolyethylene Glycols

Autor:innen und Institutionen

  • Laboratory of Radiopharmaceutics, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China. quantang@bnu.edu.cn.
  • China National Institute for Food and Drug Control, Institute of Chemical Drug Control, HuaTuo Road 29, Beijing, 100050, China. yangliu@nifdc.org.cn.

ORCID-Profile: Zhong-Lin Lu, Yang Liu

Förderung

  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Sun, X. Y., Liang, Y. X., Gao, Y. N., Zhang, X., Liu, R., Tang, Q., Lu, Z. L., & Liu, Y. (2023). [12]aneN 3 -modified camptothecin and PEGylated AIEgens co-assembly into core–shell nanoparticles with ROS/NTR dual-response for enhanced cancer therapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d3tb01282d

Vancouver

Sun XY, Liang YX, Gao YN, Zhang X, Liu R, Tang Q, et al. [12]aneN 3 -modified camptothecin and PEGylated AIEgens co-assembly into core–shell nanoparticles with ROS/NTR dual-response for enhanced cancer therapy. Journal of Materials Chemistry B. 2023. doi:10.1039/d3tb01282d

BibTeX
@article{Sun2023,
  author = {Sun, Xue-Yi and Liang, Ya-Xuan and Gao, Yi-Nan and Zhang, Xi and Liu, Rui and Tang, Quan and Lu, Zhong-Lin and Liu, Yang},
  title = {[12]aneN 3 -modified camptothecin and PEGylated AIEgens co-assembly into core–shell nanoparticles with ROS/NTR dual-response for enhanced cancer therapy},
  journal = {Journal of Materials Chemistry B},
  year = {2023},
  doi = {10.1039/d3tb01282d}
}
Kostenlos starten →